Stratification of Anatomical Imaging Features Between High-Risk and Non-High-Risk Groups in Neuroblastoma

被引:0
|
作者
Wang, Haoru [1 ]
Chen, Xin [1 ]
He, Ling [1 ]
Cai, Jinhua [1 ]
机构
[1] Chongqing Med Univ, Natl Clin Res Ctr Child Hlth & Disorders, Dept Radiol,Childrens Hosp,Chongqing Key Lab Child, Minist Educ Key Lab Child Dev & Disorders, 136 Zhongshan Rd 2, Chongqing 400014, Peoples R China
关键词
children; computed tomography; image-defined risk factors; magnetic resonance imaging; neuroblastoma; CLASSIFICATION-SYSTEM; SINGLE;
D O I
10.1177/10732748251315883
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Background: This study compared anatomical imaging features between high-risk and non-high-risk groups in neuroblastoma with at least one image-defined risk factor (IDRF). It also assessed the diagnostic performance of these features in identifying the high-risk group. Methods: A retrospective analysis of neuroblastoma patients with at least one IDRF was conducted. Imaging features, including estimated tumor volume and IDRFs, were compared between the two groups. The diagnostic performance of these features was assessed using receiver operating characteristic (ROC) curves, and the areas under the ROC curves (AUCs) along with their 95% confidence intervals (CIs) were calculated. Additionally, to internally validate their diagnostic performance, the bootstrap resampling method with 1000 bootstrap resamples was employed. Results: The study included 255 patients (185 high-risk cases, 70 non-high-risk cases). Significant differences were found in estimated tumor volume and IDRF number between the high-risk and non-high-risk groups (P < 0.001). The estimated tumor volume and the IDRF number-based cluster were independent risk factors, and their combination achieved an AUC of 0.801 (95% CI: 0.747-0.848) for high-risk group diagnosis, with the average AUC of the 1000 bootstrap samples of 0.800 (95% CI: 0.798-0.802). In abdominal lesions, specific IDRF categories differed between high-risk and non-high-risk groups (P < 0.05). Conclusion: Our study reveals anatomical imaging differences between high-risk and non-high-risk groups in neuroblastoma with at least one IDRF.
引用
收藏
页数:12
相关论文
共 50 条
  • [41] Eflornithine for treatment of high-risk neuroblastoma
    Jiang, Jianxiong
    Yu, Ying
    TRENDS IN PHARMACOLOGICAL SCIENCES, 2024, 45 (06) : 577 - 578
  • [42] Dinutuximab: A Review in High-Risk Neuroblastoma
    Hoy, Sheridan M.
    TARGETED ONCOLOGY, 2016, 11 (02) : 247 - 253
  • [43] A Safer Regimen for High-Risk Neuroblastoma
    Felix, Carolyn A.
    PEDIATRIC BLOOD & CANCER, 2009, 53 (01) : 3 - 6
  • [44] Immunocombination therapy for high-risk neuroblastoma
    Kroesen, Michiel
    Lindau, Dennis
    Hoogerbrugge, Peter
    Adema, Gosse J.
    IMMUNOTHERAPY, 2012, 4 (02) : 163 - 174
  • [45] Rethinking high-risk neuroblastoma treatment
    Cohn, Susan L.
    Pearson, Andrew D. J.
    PEDIATRIC BLOOD & CANCER, 2022, 69 (08)
  • [46] The genetic landscape of high-risk neuroblastoma
    Pugh, Trevor J.
    Morozova, Olena
    Attiyeh, Edward F.
    Asgharzadeh, Shahab
    Wei, Jun S.
    Auclair, Daniel
    Carter, Scott L.
    Cibulskis, Kristian
    Hanna, Megan
    Kiezun, Adam
    Kim, Jaegil
    Lawrence, Michael S.
    Lichenstein, Lee
    McKenna, Aaron
    Pedamallu, Chandra Sekhar
    Ramos, Alex H.
    Shefler, Erica
    Sivachenko, Andrey
    Sougnez, Carrie
    Stewart, Chip
    Ally, Adrian
    Birol, Inanc
    Chiu, Readman
    Corbett, Richard D.
    Hirst, Martin
    Jackman, Shaun D.
    Kamoh, Baljit
    Khodabakshi, Alireza Hadj
    Krzywinski, Martin
    Lo, Allan
    Moore, Richard A.
    Mungall, Karen L.
    Qian, Jenny
    Tam, Angela
    Thiessen, Nina
    Zhao, Yongjun
    Cole, Kristina A.
    Diamond, Maura
    Diskin, Sharon J.
    Mosse, Yael P.
    Wood, Andrew C.
    Ji, Lingyun
    Sposto, Richard
    Badgett, Thomas
    London, Wendy B.
    Moyer, Yvonne
    Gastier-Foster, Julie M.
    Smith, Malcolm A.
    Auvil, Jaime M. Guidry
    Gerhard, Daniela S.
    NATURE GENETICS, 2013, 45 (03) : 279 - 284
  • [47] Outcome of children with high-risk neuroblastoma
    Fluchel, M
    Hawkins, DS
    Felgenhauer, J
    Douglas, JJ
    Sanders, JE
    Park, JR
    PEDIATRIC RESEARCH, 2003, 53 (04) : 300A - 301A
  • [48] The Role of Surgery in High-risk Neuroblastoma
    Ryan, Anne L.
    Akinkuotu, Adesola
    Pierro, Agostino
    Morgenstern, Daniel A.
    Irwin, Meredith S.
    JOURNAL OF PEDIATRIC HEMATOLOGY ONCOLOGY, 2020, 42 (01) : 1 - 7
  • [49] Evolving treatments in high-risk neuroblastoma
    Kumar, Abhinav
    Rocke, John P. J.
    Kumar, B. Nirmal
    EXPERT OPINION ON ORPHAN DRUGS, 2020, 8 (12): : 497 - 506
  • [50] The Influence of Sarcopenia on High-Risk Neuroblastoma
    Kawakubo, Naonori
    Kinoshita, Yoshiaki
    Souzaki, Ryota
    Koga, Yuhki
    Oba, Utako
    Ohga, Shouichi
    Taguchi, Tomoaki
    JOURNAL OF SURGICAL RESEARCH, 2019, 236 : 101 - 105